As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

11/26/08  Biotechnology Value Fund LP       4          %Own.,Oth.² 1:14K  Neurocrine Biosciences Inc.       Lampert Mark N           
          Biotechnology Value Fund II LP
          BVF Inc./IL
          BVF Investments LLC
          BVF Partners LP/IL
11/26/08  Biotechnology Value Fund LP       4          %Own.,Oth.² 1:17K  Ligand Pharmaceuticals Inc.       Lampert Mark N           
          Biotechnology Value Fund II LP
          BVF Inc./IL
          BVF Investments LLC
          BVF Partners LP/IL
11/24/08  Biotechnology Value Fund LP       SC 13D/A               2:285K EPIRUS Biopharmaceuticals, Inc.   K&L Gates LLP/DC/FA      
          Biotechnology Value Fund II, L.P.³
          BVF Inc.³
          BVF Investments, L.L.C.³
          BVF Partners L.P.³
          Investment 10, L.L.C.³
11/24/08  BVF Inc./IL                       4          %Own.,Oth.² 1:17K  Ligand Pharmaceuticals Inc.       Lampert Mark N           
          Biotechnology Value Fund II LP
          Biotechnology Value Fund LP
          BVF Investments LLC
          BVF Partners LP/IL
11/24/08  Avigen Inc./DE                    8-K/A:5,9  11/21/08    3:297K                                   DG3/FA                   
11/24/08  Avigen Inc./DE                    8-A12G                 1:14K                                    DG3/FA                   
11/24/08  Avigen Inc./DE                    8-K:1,3,9  11/21/08    5:346K                                   DG3/FA                   

____________
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-A12G	Registration Statement for a Class of Securities — Form 8-A.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.